Discontinuation and remission rates and social functioning in patients with schizophrenia receiving second-generation antipsychotics: 52-week evaluation of JUMPs, a randomized, open-label study.
Jun IshigookaKazuyuki NakagomeTetsuro OhmoriNakao IwataKen InadaJun-Ichi IgaTaro KishiKiyoshi FujitaYuka KikuchiToshiaki ShichijoHideaki TabuseShotatsu KoretsuneHiroshi TeradaHaruko TeradaToshifumi KishimotoYuichiro TsutsumiYoshiki KandaKazutaka OhiKanji SekiyamaPublished in: Psychiatry and clinical neurosciences (2021)
All three SGAs evaluated in this study showed similar treatment discontinuation rates in patients with chronic schizophrenia in Japan.